SOPA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
SOPA is not a good buy right now. With no Intellectia buy signals, weakening/negative momentum (MACD below zero), and Q3 revenue shrinking YoY, the risk/reward doesn’t favor an impatient buyer chasing an entry today. The stock is sitting just above support (~2.03); it may bounce, but there’s no strong confirmation to justify buying immediately.
Price/Trend: SOPA is down -5.70% to 2.11 in the regular session (pre-market +0.62%), underperforming a down tape (S&P 500 -0.5%). Momentum: MACD histogram is -0.0818 (below 0) and negatively contracting—still bearish momentum, though the contraction suggests downside pressure may be easing rather than reversing. RSI(6) ~43 is neutral-to-soft (not oversold), so there isn’t a clear rebound signal yet. Moving averages are converging, which often precedes a larger move, but direction is not confirmed. Levels: Pivot 2.34 is overhead; price below pivot implies sellers still control. Support S1 2.031 is close—if it breaks, next support is S2 1.839. Resistance levels to reclaim are 2.34 then 2.649. Pattern-based outlook provided: similar-pattern stats imply a 70% chance of modest gains (+1.04% next day, +3.4% next week, +10.48% next month), but that conflicts with current bearish momentum and offers no timing edge for an immediate entry.
Intellectia Proprietary Trading Signals
and MACD bearishness is contracting (selling pressure may be stabilizing). Gross margin improvement in the latest quarter could support a narrative of operational improvement if it persists. Pattern-based model suggests a probabilistic upside bias over 1 week to 1 month (though not a timing signal).
Immediate momentum is still bearish (MACD below zero) and price is below the 2.34 pivot, keeping the trend biased down unless it reclaims key levels. Revenue declined -17.63% YoY in 2025/Q3, which is a fundamental headwind. No news catalysts in the past week to re-rate the stock, and trading trends show hedge funds/insiders are neutral (no supportive flow signal). A break below ~2.03 raises downside risk toward ~1.84.
Latest quarter: 2025/Q3. Revenue fell to 1,380,382 (-17.63% YoY), indicating weakening top-line momentum. Net income improved to -5,118,989 (still a loss, but improved YoY per the provided data), and EPS improved to -0.84 (75% YoY improvement), suggesting losses narrowed. Gross margin rose to 64.28 (strong improvement YoY), which is constructive, but the revenue contraction keeps overall growth quality weak.
No analyst rating or price target change data was provided, so there’s no clear Wall Street pro/con consensus to lean on. Based on available data only: Pros would be margin/EPS improvement; cons would be shrinking revenue, ongoing losses, and lack of clear technical buy signals.
